No Record Found
Sector
PharmaceuticalsOpen
₹170.35Prev. Close
₹170.35Turnover(Lac.)
₹2.9Day's High
₹174.3Day's Low
₹16552 Week's High
₹33052 Week's Low
₹162.2Book Value
₹111.88Face Value
₹10Mkt Cap (₹ Cr.)
52.95P/E
13.75EPS
12.39Divi. Yield
1.17No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
| Equity Capital | 3.18 | 3.18 | 3.18 | 3.18 | 
| Preference Capital | 0 | 0 | 0 | 0 | 
| Reserves | 32.38 | 28.76 | 23.64 | 18.36 | 
| Net Worth | 35.56 | 31.94 | 26.82 | 21.54 | 
| Minority Interest | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Revenue | 22.67 | 21.28 | 16.59 | 15.44 | 
| yoy growth (%) | 6.55 | 28.24 | 7.45 | 0.7 | 
| Raw materials | -10.72 | -9.27 | -7.74 | -6.76 | 
| As % of sales | 47.29 | 43.56 | 46.64 | 43.79 | 
| Employee costs | -3.88 | -3.48 | -2.72 | -3.06 | 
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Profit before tax | 3.96 | 3.9 | 9.36 | 1.14 | 
| Depreciation | -0.05 | -0.02 | -0.31 | -0.55 | 
| Tax paid | -1.02 | -0.91 | -2.53 | -0.68 | 
| Working capital | -6.69 | 2.44 | 9.78 | -1.16 | 
| Other operating items | 
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 | 
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 6.55 | 28.24 | 7.45 | 0.7 | 
| Op profit growth | 7.74 | 57.95 | 9.86 | 28.16 | 
| EBIT growth | 1.01 | -58.6 | 531.49 | 58.04 | 
| Net profit growth | -1.76 | -54.16 | 1,311.97 | 95.49 | 
No Record Found
| Company Name | LTP (₹) | P/E  (%) | Mkt.Cap  (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield  (%) | Sales Qtr  (₹.Cr) | Book Value (₹) | 
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.6 | 82.06 | 4,08,750.71 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
| Divis Laboratories Ltd DIVISLAB | 6,653.65 | 75.61 | 1,76,633.5 | 557 | 0.45 | 2,357 | 561.08 | 
| Cipla Ltd CIPLA | 1,540.5 | 23.94 | 1,24,437.16 | 1,210.53 | 1.04 | 4,495.16 | 411.56 | 
| Torrent Pharmaceuticals Ltd TORNTPHARM | 3,600.9 | 61.3 | 1,21,865.35 | 551 | 0.17 | 2,567 | 224.34 | 
| Mankind Pharma Ltd MANKIND | 2,445.75 | 55.79 | 1,00,950.41 | 412.76 | 0 | 2,541.36 | 354.69 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & MD
Rajesh Pokerna
Executive Director / Whole Time Director / CFO
Sunil Jain Kumar.
E D & Wholetime Director
Sanjoy Kumar Jain
E D & Wholetime Director
Seema Jain
E D & Wholetime Director
Manish Kumar Jain
Independent Non Exe. Director
Pradeep Kumar Jain
Independent Non Exe. Director
Manish Jain
Independent Non Exe. Director
Ashok Kumar Jain
Independent Non Exe. Director
Kodakandla Sudarshanam
Independent Non Exe. Director
Vinod Kumar Jain
Company Sec. & Compli. Officer
SANTOSH KUMAR JHA
Shed No 42 Phase II IDA,
Mallapur,
Telangana - 500076
Tel: 91-40-23437617/23437623
Website: http://www.vasundhararasayans.in
Email: vasundhararasayanslimited@gmail.com, info@vrlindia
214 RaghavaRatna Tow,
Chiragali Lane, Abids,
Hyderabad 500001
Tel: 91-040-23202465/2320
Website: www.cilsecurities.com
Email: cilsec@hotmail.com
Summary
Vasundhara Rasayans Limited was incorporated in March, 1987. The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients  with annual cap...
Read More
Reports by Vasundhara Rasayans Ltd








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.